SEC Form 4 · accession 0001179110-18-003970
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James DArecca
Officer — Chief Accounting Officer
Period of report
Mar 8, 2018
Accepted (ET)
Mar 9, 2018 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1 | Mar 8, 2018 | F | 79 | $153.50 | D | 5,600 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.